Is there really a yin and yang to VEGF-targeted therapies?

Lee M. Ellis; David A. Reardon

doi:10.1016/S1470-2045(10)70161-3

Is there really a yin and yang to VEGF-targeted therapies?

Lee M. Ellis, David A. Reardon

Surgical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	809-811
Number of pages	3
Journal	The lancet oncology
Volume	11
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(10)70161-3
State	Published - Sep 2010

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(10)70161-3

Cite this

@article{9a16a68543164b4da3dd7c2f43d4b80b,

title = "Is there really a yin and yang to VEGF-targeted therapies?",

author = "Ellis, {Lee M.} and Reardon, {David A.}",

year = "2010",

month = sep,

doi = "10.1016/S1470-2045(10)70161-3",

language = "English (US)",

volume = "11",

pages = "809--811",

journal = "The lancet oncology",

issn = "1470-2045",